# The Central Hospital of Huanggang

Organization · id `cardio:org-the-central-hospital-of-huanggang` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=The+Central+Hospital+of+Huanggang>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: The Central Hospital of Huanggang
- Sponsor class: OTHER

## Connected pages

- Sponsors: SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial (`cardio:ct-nct05159947`)
- Sponsors: Tirofiban After Successful MT Recanalization in AIS (`cardio:ct-nct06265051`)
- Sponsors: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke (`cardio:ct-nct06696820`)

## Provenance

Content hash: ae2aafd3eb6dd79d66bcabe4f95031189ba60637ca65713addbcb135db90d533
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
